Sholehvar David 4
4 · NEOGENOMICS INC · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Sholehvar David
President, Clinical Services
Transactions
- Award
Common Stock
2022-04-01+30,864→ 30,864 total - Award
Stock Option (Right to Buy)
2022-04-01+66,372→ 66,372 totalExercise: $12.15Exp: 2029-04-01→ Common Stock (66,372 underlying)
Footnotes (2)
- [F1]On April 1, 2022, Dr. Sholehvar was granted 30,864 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.